Recherche
-
Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
(Nutrition, metabolism, and cardiovascular diseases. vol. 28, n° 6, pp. 533-542, 2018-06)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre accès -
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
(Thérapie. vol. 74, n° 4, pp. 469-476, 2019)Article de revue -
Risk of Serious Trauma with Glucose-Lowering Drugs in Older Persons: A Nested Case-Control Study
(Journal of the American Geriatrics Society. vol. 66, n° 11, pp. 2086-2091, 2018-11)Article de revue -
Use of Lipid-Lowering Drugs and the Risk of Cataract: A Population-Based Nested Case-Control Study
(Clinical Pharmacology and Therapeutics. vol. 105, n° 2, pp. 458-465, 2019)Article de revue -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès